在侵袭性叶状乳腺癌中,状淋巴结转移的预后值
M Deberti1, C Goupille2, F Arbion3
1Department of Gynaecology, Centre Hospitalier Régional Universitaire de Tours, Hôpital Bretonneau, 2 boulevard Tonnellé 37044 Tours, France; François-Rabelais University, Tours, France.
Journal of gynecology obstetrics and human reproduction
|September 21, 2023
概括
淋巴结的参与显著影响侵袭性叶状腺癌患者的生存率. 淋巴结比 (LNR) 是整体存活率和远程无转移存活率的可靠预测指标.
科学领域:
- 在瘤学瘤学.
- 手术病理学手术病理学
- 乳腺癌研究研究 乳腺癌研究
背景情况:
- 状淋巴结状况是乳腺癌的关键预后因素,特别是侵入性导管癌.
- 关于淋巴结参与侵袭性叶状腺癌 (ILC) 的预后意义的数据有限.
研究的目的:
- 评估淋巴结干扰对ILC患者整体存活率 (OS) 和远程无转移存活率 (DMFS) 的预后影响.
- 评估淋巴结比率 (LNR) 在ILC预测结果中的作用.
主要方法:
- 在2007年至2018年期间接受治疗的ILC患者的一项单心观察性研究.
- 基于LNR类别的OS和DMFS分析:低风险 (≤0.2),中等风险 (>0.2≤0.65) 和高风险 (>0.65).
主要成果:
- 在LNR组中观察到OS和DMFS的显著差异 (p < 0.0001).
- 五年OS率在94% (N0) 到58.5% (高风险LNR) 之间.
- 五年DMFS的发病率从98.2% (N0) 到60.3% (高风险LNR) 之间.
- 多变量分析确定了LNR风险类,年龄,组织学类型和临床炎症作为OS的独立因素.
- 临床炎症,LVSI和LNR风险类是DMFS的独立因素.
结论:
- 淋巴结的参与,用LNR量化,显著影响ILC患者的存活率.
- 在ILC中,LNR作为可靠的预后标记,用于预测OS和DMFS.
相关概念视频
Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Metastasis
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...


